Transaction in Own Shares

Summary by AI ^BETAClose X

Bellevue Healthcare Trust PLC announced a transaction in its own shares on November 4, 2025, purchasing 704,613 ordinary shares on the London Stock Exchange at an average price of 129.37p per share. The company intends to hold these acquired shares in treasury, bringing its total treasury holding to 207,905,269 ordinary shares. Following this buyback, the number of ordinary shares in issue, excluding those held in treasury, now stands at 107,247,040. This reduction in outstanding shares could positively influence earnings per share.

Disclaimer*

Bellevue Healthcare Trust PLC

05 November 2025

Bellevue Healthcare Trust plc
Transaction in own shares

Bellevue Healthcare Trust plc (the "Company") announces that it purchased the following number of its ordinary shares of 1 penny each on the London Stock Exchange through J.P. Morgan Securities plc.

Date of purchase:	04 November 2025
Number of ordinary shares purchased:	704,613
Trading venue	LSE
Average price paid per share:	129.37p

The Company intends to hold the purchased shares in treasury.

Following the above transaction, the Company holds 207,905,269 of its ordinary shares in treasury and has 107,247,040 ordinary shares in issue (excluding treasury shares).

The Company's LEI is: 213800HQ3J3H9YF2UI82

Enquiries:
Bellevue Asset Management (UK) Ltd.
Mark Ghahramani
Telephone: +44 (0) 203 326 2981

J.P. Morgan Cazenove
James Bouverat (Sales)
Telephone: +44 (0) 207 134 2224

NSM Funds (UK) Limited
Brian Smith, Ciara McKillop
Contact: bellevue@nsm.group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END